| # | Drug | Count |
|---|---|---|
| 0 | AZACITIDINE | 4 |
| 1 | AZACITIDINE FOR | 4 |
| 2 | VENETOCLAX | 4 |
| 3 | BLEOMYCIN SULFATE | 3 |
| 4 | BRENTUXIMAB VEDOTIN | 3 |
| 5 | DACARBAZINE | 3 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 2 |
| 7 | ASPIRIN | 1 |
| 8 | ASPIRIN 325 MG | 1 |
| 9 | ASPIRIN 81 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRALSETINIB | 1 | 0.0006 |
| 1 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 2 | DACARBAZINE | 3 | 0.0004 |
| 3 | BLEOMYCIN SULFATE | 3 | 0.0003 |
| 4 | SACITUZUMAB GOVITECAN | 1 | 0.0002 |
| 5 | DAROLUTAMIDE | 1 | 0.0002 |
| 6 | BENDAMUSTINE HYDROCHLORIDE | 2 | 0.0002 |
| 7 | AZACITIDINE | 4 | 0.0001 |
| 8 | VENETOCLAX | 4 | 0.0001 |
| 9 | BENDAMUSTINE HCL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |